ACTAS UROLOGICAS ESPANOLAS, cilt.45, sa.5, ss.359-365, 2021 (SCI-Expanded)
Objective: To investigate the diagnostic efficiency of systemic immune response (SII) in prostate cancer (PCa) in patients with PSA < 10 ng/ml undergoing fusion prostate biopsy.